The @uofuhealth.bsky.social @parcka.bsky.social representing at #amersa2025 with over 22 attendees. Time to celebrate addiction research at UofU and #VASLCHCS. Go #PARCKA!!!

Nice to see this @jamanetworkopen.com paper first authored by Sophia Huebler, a PhD student (!) @utah.edu released today. #buprenorphine rx for #OUD has dramatically shifted to non-addiction specialty care settings in @deptvetaffairs.bsky.social @parcka.bsky.social jamanetwork.com/journals/jam...

Nice to see Marcie Gray from #USARA present at #AMERSA2024 in Portland. USARA is doing an awesome job at providing rural peer support and peer support coaching. #PARCKA @parcka.bsky.social

Looking forward to @AHSR2026 in #SaltLakeCity! Did you know attendees can get from the (NEW!) #SaltLakeCityAirport on the Trax!?! No cab or uber needed! Its a 25 minute ride on the TRAX Green Line from Airport to Courthouse station ... $2.50 a person! Avoid making more smog. #AHSR2026 = EcoFriendly!

Getting excited about #AHSR2026 hosted by #PARCKA and #UniversityofUtah in October! The agenda is looking fabulous for a 3 day conference, with a special day for #rural and #indiginouspopulation foci. Plenary speakers to be announced soon! medicine.utah.edu/internal-med...

As #CPDD2026 #CPDD26 #RSA2026 #RSA26 roll on, I am MOST looking forward to #AHSR #AHSR2026 ... a return to @parcka.bsky.social at the @utah.edu. After a successful #AHSR2019...#AHSR2026 is downtown hashtag#SaltLakeCity in October 2026! medicine.utah.edu/internal-med...

Cool work with fellow investigators at the @VASLCHCS, @parcka.bsky.social, and @utah.edu where we explore outcomes of patients with #opioidusedisorder after discharge. Published this week in @jamaIM jamanetwork.com/journals/jam...

I'm still proud of my service, even while all around me are worried about how others value this service.

An effect of federal downsizing: a VA steward was released: she facilitated the voices of patients with opioid addiction to provide valuable feedback to VA investigators to address opioid addiction among veterans. She championed Veteran voices. We are losing people that impact Veteran outcomes.

In the newest #episode of Let's Talk About Drugs in the Intermountain West #LTAD we sit down with Dr. Amanda Mclearn-Montz, a dedicated Triple Board resident at the University of Utah to learn more about what brought her to this work & what's still to come in her career. Listen now!

I'm a federal employee for ~25 years. I could have been paid 2-3x more in the private sector. I choose government service as a physician to take care of Veterans who are homeless & who have substance use disorders. Many colleagues have followed me into this service. I am a proud federal employee.

I'm a federal employee for ~25 years. I could have been paid 2-3x more in the private sector. I choose government service as a physician to take care of Veterans who are homeless & who have substance use disorders. Many colleagues have followed me into this service. I am a proud federal employee.

Congrats to @ATaylorKelley and @DrAudreyJones @vasaltlakecity @SLC_IDEAS for being awarded Collaborative Interprofessional Research and Clinical LEarning in Addictions VA (#CIRCLE) fellowship. A new site for #IAFAT. medicine.utah.edu/internal-med...

That's right, the Addiction Health Services Research #AHSR Conference is making its way back to #UT in 2026! 🎉 In 2019 #PARCKA hosted #AHSR in #ParkCity, but this time we are taking it to #UT's #capital city! 🌃 Learn more at tinyurl.com/parckaahsr

This week many from the #PARCKA team #collaborated with the Utah Navajo Health System to learn more about the Navajo #Wellness Model & the importance of cultural teachings in improving health ❤️

Was with the @parcka.bsky.social @utah.edu team at southern Utah at the #NavahoNation and #UNHS Wellness event. Its a retreat. It's fabulous. Its a nice reprieve from the federal politcs. YA'AT'EEH

@parcka.bsky.social at @utah.edu is hosting #AHSR2026 ! We have dates: October 6-7 in downtown Salt Lake City! medicine.utah.edu/internal-med.... We also have a venue! saltlake.littleamerica.com Looking forward to a super conference!

#Publication #Highlight! Read about how #PARCKA & #affiliate #study teams aimed to establish a hierarchy of existing #SUD care transition models in 2 categories—effectiveness and implementation—using an expert consensus approach. Read it now @ journals.lww.com/journaladdic...

#PARCKA had quite the year! 🥳 Let's #Recap2024 before it comes to an end 🪩🩵

Rural VA patients with OUD are less likely to receive methadone or naltrexone but more likely to get buprenorphine compared to urban peers. Equitable access to MOUD remains a challenge. Learn more: https://buff.ly/4gKf4Nq #PsychSciSky #AddictionSci #DrugSky

Did you know that AMERSA hosts events like free advocacy-themed webinars and advocacy ‘office hours’ that may be able to help you advance your advocacy priorities in 2025? Look out for announcements and join our listserv to stay apprised of upcoming AMERSA advocacy events. amersa.org/amersa-advoc...

Appreciate co-authors @adamjgordon.bsky.social and others for their collaboration and @FOREfdn for supporting this research

The Utah Program to Provide Pain Research Knowledge (#UP3RK) T90/R90 is accepting applications of postgraduate training to address #pain and #addiction. Wanna evolve into an independent #NIDA researcher? It’s your ticket. medicine.utah.edu/internal-med...

4/ Addressing systemic barriers and stigma and supporting clinicians who prescribe buprenorphine for opioid use disorder is crucial for improving treatment access. Read the full paper here: journals.sagepub.com/doi/abs/10.1...

3/ Even in counties with high opioid overdose rates, the removal of the X-waiver didn't significantly impact buprenorphine access.

2/ We explored if removing the X-waiver improved treatment access by examining whether buprenorphine prescriptions increased in counties with higher OD rates and fewer waivered prescribers compared to others. We found no significant effect of the X-waiver elimination on buprenorphine dispensation

1/ Excited to share recent paper, "Examining the Impact of Eliminating the X Waiver on Buprenorphine Dispensation in 63 Counties in Pennsylvania," in @sajamersa.bsky.social led by @beccabilden.bsky.social

“life of an artist” some of you will appreciate this. #photography #believeinfilm #art #artist continue to make work (for yourself)

2024 has been a fabulous year @ #SAj. We take this opportunity to honor all our outstanding #peerreviewers 4 their outstanding contribution 2 SAj-but more importantly-their contribution 2 advancing #addictionscience. Thank you peer reviewers @ SAj & other scholarly #addictionjournals 4 all you do!

Our team has had its annual #gingerbreadhouse competition, which means it is officially the #holidayseason around here! We hope everyone has had a nice start to their holidays! 🎄⛄️❄️

Looking for reviewers before Christmas

@parcka.bsky.social PODCAST! For our last episode of Let's Talk About Drugs in the Intermountain West of 2024, we talk about ways to give the gift of support to ourselves and others during the holiday season. We wish you all happy holidays... podcasts.apple.com/us/podcast/a...

@societygim.bsky.social leaders relaxing after highly productive sessions advancing leadership skills

New JAMA Internal Med study shows that when an entire healthcare system was intensively reducing #opioid doses on all patients those volunteering for a clinical trial encouraging dose reduction also reduced doses There was no major benefit or harm to participants jamanetwork.com/journals/jam...

Lights! Camera! Action! We were recently joined by our board member extraordinaire Shauna Filion to film something very special for #GivingDay happening April 8-9, 2025! It’s not too early to think about how you’ll give this #GivingDay and we hope you will consider #giving to #PARCKA this April!

Read all about #CTN-0138 in Addiction Science and Clinical Practice 📘 CTN-0138 is a #NIDA Clinical Trials Network #CTN study being led by our team at Greater Intermountain Node #GIN & with our partners at the Ohio Valley Node #OVN. Read the #protocol paper now at pmc.ncbi.nlm.nih.gov/articles/PMC...

Recovery can bring warmth and a smile to a cold day. You are not alone on your recovery journey! If you are struggling with the use of substances use and need some extra support this season, SAMHSA has resources to help: samhsa.gov/find-help

Got our tree and cross country skied all at the same time! #christmas #utah

AUTHORS' OWN WORDS: "They Ask ?s, But They Don’t Want the Answers”:Perceptions of Clinical Communication Among Veterans Discontinuing #Buprenorphine for the Treatment of #OpioidUseDisorder "...patient-centered communication...could improve the patient experience" journals.sagepub.com/doi/abs/10.1...

#PARCKA is now on #Bluesky and we're #happy to be here! Give us a follow to stay up to date with everything #PARCKA has going on! 2024 was busy, but 2025 might just be busier....🤩

@parcka.bsky.social has a new podcast out! Episode 31! podcasts.apple.com/us/podcast/l...

AUTHORS' OWN WORDS: Review: "... research [on] Electronic-Screening, Brief Intervention & Referral to Treatment (e- #SBIRT) is concentrated exclusively on higher-risk #substanceuse." Also, a lack of consensus re effectiveness of e-SBIRT for #addictivedisorders journals.sagepub.com/doi/full/10....

this is part of why it's so harmful to use legal coercion to treat addiction... jail disrupts medical care, judges & cops often oppose the treatment that is most effective & there's not a single medical condition in which jail is the best place to get care.

Scientists, academics, researchers: We’re excited to share that @altmetric.com is now tracking mentions of your research on Bluesky! 🧪

Excited to share this new study! We examine how state policies facilitating telehealth impacted buprenorphine treatment for opioid use disorder early in the COVID pandemic. #HealthPolicy 🧵 Learn more: link.springer.com/article/10.1...

AUTHORS' OWN WORDS: "Average #Buprenorphine daily dose(BDD) Trajectories for Episodes of #Buprenorphine Tx for #OpioidUseDisorder #OUD. BDD ranges widely & patient characteristics are significantly different between those episodes after differing BDD trajectories journals.sagepub.com/doi/abs/10.1...

AUTHORS' OWN WORDS: "Association of #Opioid & Concurrent #Benzodiazepine, Skeletal Muscle Relaxant, & #Gabapentinoid Usage on Healthcare Expenditure and Resource Utilization...attention must be paid to ensuring safe & effective use of concurrent CNS depressants journals.sagepub.com/doi/full/10....

Happy Thanksgiving from our family to yours.

AUTHORS' OWN WORDS: "...many correctional facilities do not conduct routine screens for #opioid & #methamphetamine use disorders [ #OUD #MUD ]...Evidence suggests that UNCOPE [a 6item brief screen] is a practical and efficient approach to identifying OUD & MUD." journals.sagepub.com/doi/abs/10.1...